Prof. Dr. Richard Greil
Head of the IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria
Dr. Simon P. Gampenrieder
IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria
Dr. Gabriel Rinnerthaler
IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer, Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria
Luca Gianni MD
Michelangelo Foundation, Milan, Italy
Dr. Iosifina Foskolou
Prof. R. Johnson’s Group, Evelyn Trust Patrick Sissons Fellow, Darwin College, Cambridge, United Kingdom; Jonas Söderquists Scholar, Karolinska Institutet, Stockholm, Sweden
Prof. Pedro Romero MD
Associate Director, Department of Fundamental Oncology, Lausanne University Hospital (CHUV), Faculty of Biology and Medicine, University of Lausanne, Switzerland
Berna Özdemir MD PhD
Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland
Onur Boyman MD
Professor and Chair of Clinical Immunology, Deputy Dean of Faculty of Medicine, University of Zurich; Director, Department of Immunology, University Hospital Zurich, Switzerland
Prof. Alberto Mantovani MD
Humanitas University, Scientific Director, Istituto Clinico Humanitas IRCCS Milan, Italy
William Harvey Research Institute, London
Marie-Agnès Doucey PhD MER
University of Lausanne and Director & Project Team Leader – Discovery, Ichnos Sciences SA, Lausanne, Switzerland
Dr. Roberto Salgado
Department of Pathology, GZA-ZNA Antwerp, Belgium; Division of Research, Peter Mac Callum Cancer Center, Melbourne, Australia
Karen Willard-Gallo MD PhD
Head, Molecular Immunology Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
Prof. Dr. Barbara Seliger
Director of the Institute for Medical Immunology, Martin Luther University, Medical Faculty, Halle, Germany
Giuseppe Curigliano MD PhD
University of Milan, Director, New Drugs and Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy
Marco Gerlinger MD FRCP
Medical Oncologist and Research Group Leader, Translational Oncogenomics Laboratory, Centre for Evolution and Cancer, Institute of Cancer Research, London, United Kingdom
Dr. Laszlo G. Radvanyi PhD
President and Scientific Director, Ontario Institute for Cancer Research, Toronto, Ontario, Canada
Dr. John Maher
Consultant and Senior Lecturer in Immunology, King’s College London, United Kingdom